We are live on ! Find out more
AMTX icon

Aemetis

74 hedge funds and large institutions have $23.5M invested in Aemetis in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 29 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 7174 (+3)

4% less capital invested

Capital invested by funds: $24.6M → $23.5M (-$1.09M)

1.4% less ownership

Funds ownership: 17.88%16.48% (-1.4%)

41% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 29

43% less call options, than puts

Call options by funds: $876K | Put options by funds: $1.53M

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
17
Reduced
29
Closed
9
Calls
$876K
Puts
$1.53M
Net Calls
-$650K
Net Calls Change
+$47K

AMTX Hedge Fund Activity: Q3 2025 in Review

74 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Aemetis (AMTX) for Q3 2025, worth a combined $23.5M — down 4.5% from $24.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new AMTX positions and 9 closed out — a net gain of 3 holders — while 17 added to existing stakes and 29 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $1.21M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $1.73M.

  • 74 institutional investors held Aemetis (AMTX) as of Q3 2025, up from 71 in Q2 2025.
  • Funds reported $23.5M of Aemetis stock for Q3 2025, down 4.5% quarter-over-quarter.
  • 12 funds opened new Aemetis positions in Q3 2025 and 9 closed out, a net change of +3 holders.
  • The largest Aemetis buyer in Q3 2025 was Susquehanna International Group, an estimated $1.21M added.
  • The largest Aemetis seller in Q3 2025 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $1.73M sold.

Based on aggregated 13F filings for Q3 2025.